1. |
PM10 and PM2.5
|
Mexico |
2016–2017 |
120 children |
Diminished olfactory identification performance and affected CNS function |
Guarneros et al. (2020) |
2. |
PM10 and PM2.5
|
13 cities of China |
2013–2015 |
111,842 hospital outpatients |
Increases mental disorders exacerbations |
Lu et al. (2020) |
3. |
PM10 and PM2.5
|
China |
2014–2015 |
16,601 anxiety hospital admissions |
Worsens the risks of anxiety hospitalizations |
Yue et al. (2019) |
4. |
PM10
|
Saxony, Germany |
2005–2014 |
1,126,014 individuals |
Increased risk of anxiety and depression |
Zhao et al. (2020) |
5. |
PM2.5
|
United Kingdom |
2006–2010 |
111,370 participants |
Increases the risk of glaucoma via neurotoxic and/or vascular effects |
Chua et al. (2019) |
6. |
PM2.5
|
Unites States |
1999–2010 |
998 participants |
Increased risk for Alzheimer's disease |
Younan et al. (2020) |
7. |
PM2.5
|
Boston, New York, Shanghai or Changsha |
2010–2014 |
135 first episode schizophrenia patients |
Interacts with psychosis to reduce hippocampal volume |
Worthington et al. (2020) |
8. |
PM2.5
|
Denmark |
1989–2014 |
21,057 cases |
Increased risk factor for CNS tumors |
Poulsen et al. (2020) |
9. |
PM2.5
|
Mexico |
2007–2011 |
509 mothers |
Increased the risk of Postpartum depression and neuropsychological dysfunction in mothers |
Niedzwiecki et al. (2020) |
10. |
PM2.5
|
Utah |
1986–2015 |
2444 pediatric patients and 13,459 young adult patients with cancer |
Increases cancer mortality in pediatric lymphomas and CNS tumors |
Ou et al. (2020a) |
11. |
PM2.5
|
Barcelona |
2012–2014 |
186 participants |
Decreased corpus callosum volume in pre-adolescent children and behavior problems |
Mortamais et al. (2019) |
12. |
PM |
West Virginian counties, USA |
2001–2005 |
Public Health and Socioeconomic Data |
Increased dementia mortality |
Salm and Benson (2019) |